4//SEC Filing
Pena Luis C. 4
Accession 0001620548-25-000009
CIK 0002044725other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:22 PM ET
Size
6.9 KB
Accession
0001620548-25-000009
Insider Transaction Report
Form 4
Evommune, Inc.EVMN
Pena Luis C.
DirectorPresident & CEO
Transactions
- Conversion
Common Stock
2025-11-07+24,225→ 682,821 total - Conversion
Series Seed Preferred Stock
2025-11-07−206,355→ 0 total→ Common Stock (24,225 underlying)
Footnotes (1)
- [F1]Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.
Documents
Issuer
Evommune, Inc.
CIK 0002044725
Entity typeother
Related Parties
1- filerCIK 0001620548
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:22 PM ET
- Size
- 6.9 KB